|
|
Article: AEterna Seeks Acquisitions In Cancer Following C$57M Financing.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
AEterna Laboratories Inc. concluded private placements that initially grossed C$57 million (US$35.7 million) for the oncology-focused company, a financing that could increase to C$180 million over the next 20 months.
One private placement was with SGF Sante, a subsidiary of Societe generale de financement du Quebec, and Solidarity Fund QFL, of Montreal. The other was with Acqua Wellington Private Placement Fund Ltd., of New York.
oMost of the money will be used for our acquisition program,o said Gilles Gagnon, vice president and chief operating officer for AEterna, of Quebec City, Quebec.
In fact, C$35 million is slated ...